People suffering from major depressive disorder have lower levels of the amino acid arginine, a new study from the University of Eastern Finland shows.
The publication of this study adds to the growing evidence that nutrient deficiencies are associated with depression. Just last year, for example, a scientific review published in Maturitas, the official journal of the European Menopause and Andropause Society, noted that low levels of B vitamins are common in patients with depression and that supplementation with these nutrients has been shown to improve depression outcomes. These findings are consistent with the key principle of Cellular Medicine that the primary cause of today’s most common chronic diseases is a long-term deficiency of vitamins and other specific nutrients.
With clinical trials similarly showing that magnesium supplements may be an alternative to antidepressant drugs, and that omega-3 supplements can help treat even major depression, the end of the pharmaceutical ‘business with mental health’ may soon be in sight.